2022

What will Quality Management look like in 2025?

by cyb2025

JAMES KELLEHER
Generis Enterprise Technology Limited, London, United Kingdom

What does the future hold for Quality Management as smart automation offers new ways to monitor and pre-emptively intervene in pharmaceutical production? Late last year, a panel of experts from Merck, Syneos Health and Accenture, chaired by James Kelleher, CEO of Generis, debated the subject.

 

The participants were:

  • Dr. Heiner Niessen, Head of Application Technology Quality & Compliance at Merck
  • Peter Brandstetter, Quality and Regulatory expert at Accenture
  • James Man, Quality subject expert and R&D Advisory Managing Director at Syneos Health.

 

ABOUT THE AUTHOR

James Kelleher, CEO of Generis, helps life science companies to decrease their time to market by providing a comprehensive platform for the core processes, data, and content of the product development lifecycle. Spanning applications across Regulatory, Quality, Safety, Clinical, and other enterprise-wide processes, Generis works with customers such as Bayer, Merck KGaA, Pfizer, BMS, Gilead, AstraZeneca and Otsuka

Login